Yarrow Bioscience, Inc. SEC filings YARW
Yarrow Bioscience, Inc. has 682 filings in SEC EDGAR's recent list, going back to Jan 7, 2013. Its latest annual report, Form ARS, was filed on Jun 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Sep 11, 2026 | — |
| 424B5 | Prospectus supplement | Sep 11, 2026 | — |
| POS AM | Filing | Aug 14, 2026 | — |
| 424B3 | Prospectus | Jun 15, 2026 | — |
| S-4/A | Filing | Jun 3, 2026 | — |
| S-4/A | Filing | Apr 28, 2026 | — |
| S-4 | Registration for a merger or exchange | Mar 31, 2026 | — |
| S-8 | Employee stock plan registration | Dec 19, 2024 | — |
| S-3 | Shelf registration | Mar 1, 2024 | — |
| S-8 | Employee stock plan registration | Mar 1, 2024 | — |
| S-8 | Employee stock plan registration | Dec 13, 2023 | — |
| 424B3 | Prospectus | Nov 22, 2023 | — |
| S-3 | Shelf registration | Nov 13, 2023 | — |
| 424B5 | Prospectus supplement | May 12, 2022 | — |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| 424B5 | Prospectus supplement | Mar 15, 2022 | — |
| 424B5 | Prospectus supplement | Aug 12, 2021 | — |
| S-3 | Shelf registration | May 6, 2021 | — |
| S-8 | Employee stock plan registration | Mar 4, 2021 | — |
| 424B5 | Prospectus supplement | Jan 27, 2021 | — |
| 424B2 | Prospectus | Jun 5, 2020 | — |
| 424B5 | Prospectus supplement | Jun 4, 2020 | — |
| S-8 | Employee stock plan registration | Mar 9, 2020 | — |
| 424B3 | Prospectus | Jan 7, 2020 | — |
| S-4/A | Filing | Jan 6, 2020 | — |
| S-4 | Registration for a merger or exchange | Dec 4, 2019 | — |
| S-8 | Employee stock plan registration | Feb 28, 2019 | — |
| S-3 | Shelf registration | Feb 1, 2019 | — |
| S-8 | Employee stock plan registration | Jan 29, 2018 | — |
| 424B4 | Prospectus | Jan 26, 2018 | — |
| S-1MEF | Filing | Jan 24, 2018 | — |
| S-1/A | Amended registration statement | Jan 23, 2018 | — |
| S-1/A | Amended registration statement | Jan 18, 2018 | — |
| S-1/A | Amended registration statement | Jan 12, 2018 | — |
| S-1 | Registration statement | Dec 28, 2017 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- YARW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1566044
- Former names
- VYNE Therapeutics Inc. (until Jul 24, 2026); Menlo Therapeutics Inc. (until Sep 2, 2020); Menlo Therapeutics, Inc. (until Jan 31, 2018); Tigercat Pharma, Inc. (until Jan 7, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.